![](https://www.pharmavoice.com/imgproxy/pHAt3ksVRRE_Ki-eFc6Z5l7SQl4IMVWkEwkAZsrJfVI/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTQ3MDgxOTg1MC5qcGc=.webp)
Has pharma emerged from the ‘age of uncertainty’?
After years of disquiet and unpredictability in the pharma markets, a new age of megablockbusters, normalized M&A and more clarity around the Inflation Reduction Act has emerged, bringing the industry’s trajectory into better focus. Following the COVID …